IHS Chemical Week

Regions :: Western Europe

Lonza and Novartis Jointly to Develop and Manufacture Biologics Products

5:18 AM MDT | July 11, 2008 | Deepti Ramesh

Lonza says it has entered into a long-term strategic partnership with Novartis for the joint development and manufacture of Novartis's biologics pipeline. R&D activities over the past few years have resulted in a sharp increase in the number of biological compounds, currently accounting for about a quarter of the Novartis development portfolio, Novartis says. The biologics unit of Novartis aims to further grow the biologics pipeline. Lonza will be involved in the development, scale-up and manufacturing of Novartis' biologics pipeline. Lonza will provide...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa